Cepha s.r.o.

Plzen 1 23 trials

23 Registered trials

0 Currently recruiting

Organisation

Cepha s.r.o.

Location

Plzen 1, Czechia

Identifier

ORG-100028156

Address

Komenskeho 19, Severni Predmesti, 323 00, Czechia

Departments

CEPHA
Clinic

Clinical trials at this site (23)

Search interface

An open label, randomized, multiple-dose, two-treatment, two-period, cross-over bioequivalence study comparing Pyridostigmine Bromide, P.R.T… Pending

2025-524219-35-00 treatment of myasthenia gravis 2
Bioequivalence study comparing two temazepam 20 mg tablet formulations after fasted administration; an open, randomized, single centre, sing… Pending

2025-524376-36-00 short-term treatment of insomnia 2
Bioequivalence study 1 to compare pharmacokinetics of Parkinson´s disease drugs in healthy volunteers Pending

2026-525448-14-00 Parkinson disease 2
Bioequivalence study 2 to compare pharmacokinetics of Parkinson´s disease drugs in healthy volunteers Ended

2026-525449-57-00 Parkinson desease 2 2026-04-08
A bioequivalence study comparing Empagliflozin 25 mg film-coated tablets, VIANEX S.A., Greece versus Jardiance 25 mg film-coated tablets, Bo… Ended

2025-524910-28-00 none - healthy volunteers 2 2026-03-09
An open label, randomized, single-dose, two-treatment, two-period, cross-over bioequivalence study comparing Pyridostigmine Bromide, P.R.Tab… Ended

2025-524218-27-00 treatment of myasthenia gravis 2 2026-01-21
An open label, randomized, single-dose, two-treatment, two-period, cross-over bioequivalence study comparing Pyridostigmine Bromide, P.R.Tab… Ended

2025-524217-89-00 treatment of myasthenia gravis 2 2025-12-04
An open-label, randomized, single-dose, two-period, two-treatment, crossover bioequivalence study with GP-IMP-001 in healthy male volunteers… Ended

2025-522921-37-00 inteneded for treatment of - active rheumatoid arthriti 2 2025-10-22
A single-dose, open-label, randomized, two-period, two-sequence, crossover pivotal bioequivalence study on 400 mg / 5 mL amoxicillin + 57 mg… Ended

2025-522562-70-00 infection 2 2025-09-08
A single-dose, open-label, randomized, two-period, two-sequence, crossover pivotal bioequivalence study on two amoxicillin-clavulanic acid f… Ended

2025-521718-24-00 infections 2 2025-07-28
A single-dose, open-label, randomized, two-period, two-sequence, crossover pivotal bioequivalence study on Taromentin® 500 mg + 125 mg film-… Ended

2025-521722-15-00 infections 2 2025-06-26
An open label, randomized, single-dose, two-treatment, two-period, cross-over pilot bioequivalence study comparing Pyridostigmine Bromide, P… Ended

2025-521177-14-00 treatment of myasthenia gravis 2 2025-05-15
A single-dose, open-label, randomized, two-period, two-sequence, crossover pivotal bioequivalence study on Dapagliflozin 10 mg film-coated t… Ended

2024-520212-18-00 intended for treatment of for the treatment of (2): • 2 2025-04-03
A pilot, open label, single dose, randomized, four-period, four-sequence, four-treatment crossover, comparative bioavailability study of UDC… Ended

2024-519920-26-00 UDCA causes a reduction in cholesterol saturation of th 2 2025-02-20
Bioequivalence study of GP-IMP-001 with regards to reference product Ended

2024-515889-14-00 healthy volunteers 2 2025-01-22
A drug-drug interaction trial in healthy female participants to investigate the effect of aprocitentan on combined hormonal contraceptives. Ended

2024-517224-19-00 Not applicable - healthy volunteer trial 3 2025-01-06
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatm… Ended

2024-515436-76-00 influenza 2 2024-11-13
Safety Assessment of 10-Day Daily Bucco-Oral Administration of Transfer Factor in Healthy Adult Human Subjects Ended

2024-511448-17-02 healthy subjects 1 2024-10-16
A single-dose, randomized, two-period, two-sequence, crossover comparative bioavailability study on formulations containing ramipril, amlodi… Ended

2024-514456-32-00 hypertension 2 2024-09-09
A randomized, single dose, cross-over bioavailability study comparing the drug-drug interaction between telmisartan tablets, indapamide tabl… Ended

2024-510835-23-00 high blood pressure 3 2024-06-19
A randomized, open-label, single dose, cross-over study to evaluate the drug-drug interaction between Proscar 5 mg, film-coated tablets and … Ended

2024-510774-24-00 healthy male subjects 3 2024-03-25
A single-dose, randomized, two-period, two-sequence, crossover pilot bioequivalence study on formulations containing rivaroxaban and acetyls… Ended

2023-509841-12-00 increased blood clotting 2 2024-02-28
A randomized, open-label, single dose, cross-over bioavailability study evaluating the drug-drug interaction between Tritace 10, 10 mg, tabl… Ended

2023-505887-12-00 NA - study in healthy subjects 3 2023-09-13